Jackson Acquisition II, a blank check company targeting healthcare, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one right to receive one-tenth of a share upon the completion of an initial business combination.
The company is led by CEO and Chairman Richard Jackson, the Chairman and CEO of healthcare staffing company Jackson Healthcare, and CFO David Lawrence, who previously held C-suite roles at Neurotrauma Sciences and Acorda Therapeutics. Jackson Acquisition II plans to target the healthcare sector, with a focus on market-leading companies, closely-held companies, institutionally-backed businesses, and corporate spin-offs.
Management's previous SPAC, Jackson Acquisition (formerly NYSE: RJAC.U) went public in December 2021 and liquidated in June 2023. The previously SPAC was Chaired by former presidential candidate Jeb Bush.
Jackson Acquisition II plans to list on the NYSE under the symbol JACS.U. Roth Capital acted as sole bookrunner on the deal.
